Moderna surges after hours on patent settlement with Arbutus and Genevant
Perspective Analysis
Comparing sources…
How outlets covered this
Left-leaning
No articles
Center
Right-leaning
No articles
Coverage Timeline
Read at source (2 outlets)
Moderna’s stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
By Claudia Assis
Read full article →

